KYTHERA Biopharmaceuticals Announces Date of FDA Advisory Committee Review of ATX-101 for the Treatment of Submental Fullness
January 23, 2015 09:00 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Jan. 23, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced the Dermatology and Ophthalmic Drugs Advisory Committee of the U.S. Food and...
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
January 20, 2015 20:47 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on January 16, 2015, the Compensation Committee of the Company's Board...
KYTHERA Biopharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference
January 05, 2015 20:37 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the...
KYTHERA Biopharmaceuticals Appoints Hollings C. Renton to Board of Directors
January 05, 2015 16:10 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that it has named Hollings C. Renton to its Board of Directors.
Mr. Renton...
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
December 12, 2014 20:20 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Dec. 12, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that the Compensation Committee of the Company's Board of Directors granted...
KYTHERA Biopharmaceuticals to Present at the Goldman Sachs US Emerging / SMID Cap Growth Conference
November 14, 2014 17:18 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Nov. 14, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at...
KYTHERA Biopharmaceuticals Releases Third Quarter 2014 Operating Results
November 10, 2014 16:05 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its third quarter 2014 and provided an update on recent...
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
November 04, 2014 20:16 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on October 31, 2014, the Compensation Committee of the Company's Board of...
KYTHERA Biopharmaceuticals to Release Third Quarter 2014 Operating Results
November 03, 2014 16:46 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its third quarter 2014 operating results and will host an...
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
October 21, 2014 17:34 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on October 17, 2014, the Compensation Committee of the Company's Board...